
Collegium Pharmaceutical COLL
$ 35.44
-2.37%
Annual report 2025
added 02-26-2026
Collegium Pharmaceutical DIO Ratio 2011-2026 | COLL
Annual DIO Ratio Collegium Pharmaceutical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 181 | 148 | 59.8 | 45.8 | 47.7 | 35.4 | 18.2 | 17.2 | 255 | 2.26 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.26 K | 17.2 | 306 |
Quarterly DIO Ratio Collegium Pharmaceutical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.4 | 43.2 | 41.3 | - | 48.1 | - | - | - | 48.7 | 43.6 | 53.8 | - | 43.3 | 51.4 | 126 | 55.3 | 51.5 | 49 | 44.2 | 44.5 | 46 | 48 | 30.7 | 17.9 | 18.8 | 18.1 | 16.2 | 24 | 15.5 | 15.2 | 10.2 | 151 | 299 | 287 | 385 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 385 | 10.2 | 72.3 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Axsome Therapeutics
AXSM
|
168 | $ 156.92 | -1.23 % | $ 7.81 B | ||
|
Kamada Ltd.
KMDA
|
166 | $ 8.5 | -1.39 % | $ 260 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
BioMarin Pharmaceutical
BMRN
|
644 | $ 54.13 | -1.64 % | $ 10.4 B | ||
|
Coherus BioSciences
CHRS
|
97.5 | $ 1.52 | -5.59 % | $ 178 M | ||
|
Cellectis S.A.
CLLS
|
23.3 | $ 3.34 | -4.02 % | $ 116 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M |